SAN

80.9

-0.21%↓

UCB

240.9

-2.71%↓

SHL.DE

36.86

-3.38%↓

ARGX

677

-1.34%↓

VIE

35.26

-0.11%↓

SAN

80.9

-0.21%↓

UCB

240.9

-2.71%↓

SHL.DE

36.86

-3.38%↓

ARGX

677

-1.34%↓

VIE

35.26

-0.11%↓

SAN

80.9

-0.21%↓

UCB

240.9

-2.71%↓

SHL.DE

36.86

-3.38%↓

ARGX

677

-1.34%↓

VIE

35.26

-0.11%↓

SAN

80.9

-0.21%↓

UCB

240.9

-2.71%↓

SHL.DE

36.86

-3.38%↓

ARGX

677

-1.34%↓

VIE

35.26

-0.11%↓

SAN

80.9

-0.21%↓

UCB

240.9

-2.71%↓

SHL.DE

36.86

-3.38%↓

ARGX

677

-1.34%↓

VIE

35.26

-0.11%↓

Kodu・Aktsiate loetelu・Nanobiotix

N
Nanobiotix

Suletud

26.94 3.3

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

25.72

Max

27.18

Põhinäitajad
By Trading Economics
Sissetulek	-13M -19M
Müük	-24M 3M
Kasumimarginaal	-618.236
Töötajad	103
EBITDA	-14M -13M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+22.57% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	20. mai 2026

Turustatistika
By TradingEconomics
Turukapital	17M 1.3B
Eelmine avamishind	23.64
Eelmine sulgemishind	26.94

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bullish Evidence

2.975 / 3.015 Toetus ja vastupanu

Nanobiotix Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. apr 2026, 23:27 UTC

Uudisväärsed sündmused

BHP Expects Annual Copper Output in Upper Half of Guidance, Finishes China Iron-Ore Negotiations

21. apr 2026, 23:27 UTC

Kuumad aktsiad

Stocks to Watch: Sonoco Products, Adobe, Manhattan Associates, Target Hospitality

21. apr 2026, 23:02 UTC

Tulu

Correction to Capital One Financial 1Q Earnings Article

21. apr 2026, 23:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

21. apr 2026, 23:47 UTC

Market Talk

Nikkei May Decline as Hopes for U.S.-Iran Peace Talks Fade -- Market Talk

21. apr 2026, 23:36 UTC

Market Talk

Uudisväärsed sündmused

Market Talk Roundup: Latest on U.S. Politics

21. apr 2026, 23:36 UTC

Market Talk

Uudisväärsed sündmused

Gold Edges Higher After Trump Says U.S. Will Extend Cease-Fire Deadline -- Market Talk

21. apr 2026, 23:32 UTC

Tulu

America Movil 1Q EBITDA MXN94.5B, Up 3.8% on Year >AMX

21. apr 2026, 23:30 UTC

Tulu

America Movil 1Q Rev MXN236.84B, Up 2.1% on Year >AMX

21. apr 2026, 23:28 UTC

Tulu

America Movil 1Q Net MXN23.4B Vs. Net MXN18.7B >AMX

21. apr 2026, 23:16 UTC

Uudisväärsed sündmused

Ampol Entered 2Q With Hedge Book Positioned to Mitigate Volatility

21. apr 2026, 23:15 UTC

Uudisväärsed sündmused

Ampol Entered 2Q With Broad-Based Momentum

21. apr 2026, 23:15 UTC

Uudisväärsed sündmused

Ampol: Suitable Crudes for Lytton Remain Available in Market

21. apr 2026, 23:14 UTC

Uudisväärsed sündmused

Ampol: Crude Supplies Secured Into July

21. apr 2026, 23:14 UTC

Uudisväärsed sündmused

Ampol: Fuel Supplies Secured Until at Least End of May

21. apr 2026, 23:13 UTC

Uudisväärsed sündmused

Ampol: Well Placed for Crude, Product Supply Prior to Iran Conflict

21. apr 2026, 23:13 UTC

Uudisväärsed sündmused

Ampol 1Q Lytton Refinery Production 1.43 Billion Liters

21. apr 2026, 23:12 UTC

Uudisväärsed sündmused

Ampol 1Q Lytton Refiner Margin US$25.45/Bbl

21. apr 2026, 22:54 UTC

Market Talk

Sell America Trade Could Gain Momentum If Fed Uncertainty Unresolved -- Market Talk

21. apr 2026, 22:49 UTC

Uudisväärsed sündmused

BHP 3Q Average Realized Energy Coal Price $105.61/Ton, Up 10% On-Quarter

21. apr 2026, 22:49 UTC

Uudisväärsed sündmused

BHP 3Q Average Realized Steelmaking Coal Price $226.76/Ton, Up 15% On-Quarter

21. apr 2026, 22:48 UTC

Uudisväärsed sündmused

BHP 3Q Average Realized Iron Ore Price $85.35/Ton, Flat On-Quarter

21. apr 2026, 22:48 UTC

Omandamised, ülevõtmised, äriostud

Alliance Portfolio Is Comprised of Five Plants: Batavia, Hillburn, Massena, Shoemaker and Sterling

21. apr 2026, 22:48 UTC

Uudisväärsed sündmused

BHP 3Q Average Realized Copper Price $5.86/Pound, Down 1% On-Quarter

21. apr 2026, 22:48 UTC

Omandamised, ülevõtmised, äriostud

PowerTransitions to Buy 323 MW of Power Generation Assets in New York State From Alliance Energy Group

21. apr 2026, 22:46 UTC

Uudisväärsed sündmused

BHP: Has Concluded Iron Ore Sales Contract Negotiations With China Mineral Resources Group

21. apr 2026, 22:45 UTC

Uudisväärsed sündmused

BHP: Pampa Norte Production Down on Ore Complexity, Variation; Declining Grades

21. apr 2026, 22:45 UTC

Uudisväärsed sündmused

BHP: Escondida Concentrator Investment Estimated Between $4.4 Billion-$5.9 Billion

21. apr 2026, 22:44 UTC

Uudisväärsed sündmused

BHP: Escondida Concentrator Project Seen Facing FID in 2027-28

21. apr 2026, 22:42 UTC

Uudisväärsed sündmused

BHP CEO: Centralized Procurement, Low-cost Operations Help Buffer Industry Wide Cost Pressures

Võrdlus sarnastega

Hinnamuutus

Nanobiotix Prognoos

Hinnasiht

By TipRanks

22.57% tõus

12 kuu keskmine prognoos

Keskmine 34 EUR 22.57%

Kõrge 34 EUR

Madal 34 EUR

Põhineb 1 Wall Streeti analüütiku instrumendi Nanobiotix 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

1 ratings

Osta

Hoia

Müü

Põhineb 1 analüütiku instrumendi Nanobiotix aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

2.975 / 3.015Toetus ja vastupanu

Recent bullish events outweigh bearish events.

Bearish events outweigh bullish events.

There is one bearish event.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Nanobiotix

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. The company has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.